2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö : 2024-03-30
±³À°ÀÏÀÚ : 2024-03-30
±³À°Àå¼Ò : ´ëÀü¾¾Á¨ÀÇ·áÀç´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦
±³À°ÁÖÁ¦ : 2024³â ´ëÇѽŰæ±Ù¿¬±¸ÇÐȸ Ãá°èÇмú´ëȸ ¹× ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ ÃæûÁöȸ ½ÉÆ÷Áö¾ö
ÁÖÃÖ±â°ü : ´ëÇѸ¶ÃëÅëÁõÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇѽŰæ±Ù¿¬±¸È¸
´ã´çÀÚ : Çѹμö
¿¬¶ôó : 031-981-2764
À̸ÞÀÏ : daonics@naver.com
±³À°Á¾·ù : ¸¶ÃëÅëÁõÀÇÇаú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ´ëÀü±¤¿ª½Ã
±³À°½Ã°£ : 6 ½Ã°£ 20ºÐ
¼¼ºÎ¼ö°·á : 50,000¿ø
ºñ°í Àü°øÀÇ ¹× ±âŸÀÇ·áÁø 2¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:00~09:40 Malignant Hyperthermia: A Practical Guide in Korea ÀÓº´°Ç(°í·ÁÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 09:40~10:20 Anesthesia and Environment ¿À¾Æ¿µ(¼¿ïÀÇ´ë)
ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:20~10:35 Break ()
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 10:35~11:00 Efficacy and Safety of Sugammadex in Children À̼ö¹Î(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:00~11:25 Sugammadex in Pregnant Women and Women of Childbearing Age ÀÌÁØÈ£(ÀüºÏÀÇ´ë)
Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:25~11:35 Q&A ()
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 11:35~12:00 Neuromuscular Blockade and Its Reversal in Geriatric Population ¼ºÅÂÀ±(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:00~12:25 Neuromuscular Blockade and Its Reversal in Musculoskeletal Disorder ÇÑÁö¿ø(Áß¾ÓÀÇ´ë)
Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:25~12:35 Q&A ()
½Ä»ç 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 12:35~13:35 Lunch ()
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 13:35~14:05 Good Clinical Research Practice (GCRP) in Neuromuscular Research ±¸Ã¢ÈÆ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:05~14:35 Common Flaws in Neuromuscular Research Á¤±âÅÂ(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 14:35~15:05 Unmet needs in Neuromuscular Research ÀÌ»ó¼®(ÀÎÁ¦ÀÇ´ë)
Åä·Ð 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:05~15:20 Q&A ()
ÈÞ½Ä 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:20~15:35 Break ()
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:35~15:50 Resistance or Tachyphylaxis to Rocuronium õº¸¸§(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 15:50~16:05 Analysis of characteristics of patients whose sugammadex claims were denied by the Auto Insurance Claims Review Department. Á¶¼ö¿¬(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:05~16:20 Response of adductor longus muscle during obturator nerve block under deep NMB ÇÏÀº±³(Á¶¼±ÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:20~16:35 Comparison of effects of sugammadex administration timing on the success rate of neuromuscular monitoring before extubation and recovery profile in patients undergoing general anesthesia À̱Կø(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 03¿ù 30ÀÏ ´ëÀü ¾¾Á¨ÀÇ·áÁ¦´Ü 6Ãþ ÄÁÆÛ·±½ºÈ¦ 16:35~16:50 Rocuronium induced anaphylaxis in robotic hysterectomy À̵¿±Ù(Ãæ³²ÀÇ´ë)